JP2015127307A - 抗ｐｒｏｋ１抗体による大腸癌の治療 - Google Patents

抗ｐｒｏｋ１抗体による大腸癌の治療 Download PDF

Info

Publication number
JP2015127307A
JP2015127307A JP2013273139A JP2013273139A JP2015127307A JP 2015127307 A JP2015127307 A JP 2015127307A JP 2013273139 A JP2013273139 A JP 2013273139A JP 2013273139 A JP2013273139 A JP 2013273139A JP 2015127307 A JP2015127307 A JP 2015127307A
Authority
JP
Japan
Prior art keywords
prok1
antibody
cancer
cells
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013273139A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015127307A5 (https=
Inventor
明夫 山口
Akio Yamaguchi
明夫 山口
孝憲 五井
Takanori Goi
孝憲 五井
俊之 中澤
Toshiyuki Nakazawa
俊之 中澤
秀崇 呉林
Hidetaka Kurebayashi
秀崇 呉林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Fukui NUC
Original Assignee
University of Fukui NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Fukui NUC filed Critical University of Fukui NUC
Priority to JP2013273139A priority Critical patent/JP2015127307A/ja
Publication of JP2015127307A publication Critical patent/JP2015127307A/ja
Publication of JP2015127307A5 publication Critical patent/JP2015127307A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2013273139A 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体による大腸癌の治療 Pending JP2015127307A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013273139A JP2015127307A (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体による大腸癌の治療

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013273139A JP2015127307A (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体による大腸癌の治療

Publications (2)

Publication Number Publication Date
JP2015127307A true JP2015127307A (ja) 2015-07-09
JP2015127307A5 JP2015127307A5 (https=) 2017-02-09

Family

ID=53837491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013273139A Pending JP2015127307A (ja) 2013-12-27 2013-12-27 抗ｐｒｏｋ１抗体による大腸癌の治療

Country Status (1)

Country Link
JP (1) JP2015127307A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022122736A (ja) * 2021-02-10 2022-08-23 国立大学法人福井大学 抗ｐｒｏｋ１抗体の利用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004511432A (ja) * 2000-06-23 2004-04-15 ジェネンテック・インコーポレーテッド Ｅｇ−ｖｅｇｆ核酸及びポリペプチド及び使用方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004511432A (ja) * 2000-06-23 2004-04-15 ジェネンテック・インコーポレーテッド Ｅｇ−ｖｅｇｆ核酸及びポリペプチド及び使用方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
日本大腸肛門病会誌, vol. Vol. 58, No. 9 第60回総会抄録号, JPN6017030895, 2005, pages p. 515 *
日本大腸肛門病会誌, vol. Vol. 65, No. 9 第67回学術集会抄録号, JPN6017030894, 2012, pages p. 627 *
癌の臨床, vol. Vol. 58, No. 6, JPN6017030893, 2012, pages pp. 341-347 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022122736A (ja) * 2021-02-10 2022-08-23 国立大学法人福井大学 抗ｐｒｏｋ１抗体の利用

Similar Documents

Publication Publication Date Title
KR102134088B1 (ko) Ror1 암을 치료하고 전이를 저해하는데 이용을 위한 항체와 백신
JP2021531826A (ja) 栄養膜細胞表面抗原２（ｔｒｏｐ２）に対する特異的な抗体
JP2022514693A (ja) Ｍｕｃ１８に特異的な抗体
TW201329103A (zh) 抗－ＥｒｂＢ３抗體及其用途
KR20200063153A (ko) Cd137을 표적화하는 항체 및 이의 사용 방법
TW201402610A (zh) 抗－ｅｇｆｒ抗體及其用途
JP2022523710A (ja) Ｃｄ４４に特異的な抗体
JP2022514786A (ja) Ｍｕｃ１８に特異的な抗体
WO2021115303A1 (zh) 一种抗Claudin18.2单克隆抗体、其制备方法及用途
WO2023143590A1 (zh) 采用抗il-11抗体的肿瘤组合疗法
WO2019076277A1 (zh) 抗pd-1抗体和抗lag-3抗体联合在制备治疗肿瘤的药物中的用途
EP2766045B1 (en) Treatment of breast cancer with companion diagnostic
US20220089757A1 (en) Anti-cd137l antibodies and methods of using same
JP6320040B2 (ja) 抗ｐｒｏｋ１抗体及び抗ｖｅｇｆ抗体併用による大腸癌の治療
US20180208656A1 (en) Anti-Prokineticin Receptor (PROKR) Antibodies and Uses Thereof
JP2015127307A (ja) 抗ｐｒｏｋ１抗体による大腸癌の治療
US20150183860A1 (en) Regimens for treatments using anti-igf antibodies
CN120865400B (zh) Fgf18中和抗体及其制备方法和应用、核酸分子、载体、细胞、药物和联合用药组合物
CN117946270B (zh) 抗cd93抗体及其用途
WO2014175160A1 (ja) ヘパリン結合上皮増殖因子様増殖因子に対する機能性モノクローナル抗体
RU2809746C2 (ru) Гуманизированное моноклональное антитело против vegf
JP2021521804A (ja) 抗ｃｄ４０抗体およびその使用
US20260116967A1 (en) Anti-pvrig antibody and application thereof
WO2011161970A1 (ja) 抗ｐｄｇｆ受容体抗体
AU2016203429B2 (en) Binding Molecules to the Human OX40 Receptor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161222

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170822

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180306